Search Legislation

The Medicines (Contact Lens Fluids and Other Substances) (Labelling) Regulations 1979

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Opening Options

 Help about opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format. The electronic version of this UK Statutory Instrument has been contributed by Westlaw and is taken from the printed publication. Read more

6.—(1) Subject to the provisions of paragraph (3) and of regulation 7, in addition to the particulars specified in regulation 5, the particulars specified in paragraph (2) shall be shown either on a label on the container in which any contact lens substance is contained or on a label on the package in which the container is immediately enclosed or in a leaflet which is supplied or intended to be supplied with such substance.

(2) The particulars specified for the purposes of paragraph (1) in relation to any contact lens substance are—

(a)the date after which it is recommended that the substance should no longer be used;

(b)a recommended period within which the substance should be used after the container containing it has first been opened;

(c)directions as to how the substance is to be used;

(d)a warning in capital letters, “DO NOT MIX WITH OTHER FLUIDS EXCEPT AS DIRECTED”; and

(e)a warning that the substance should not be administered to the eye concurrently with any eye medicament except on the advice of a doctor.

(3) Where any contact lens substance is or is to be sold or supplied in solid form as a powder or tablets—

(a)instructions as to how it is to be prepared for use, including a warning that only recommended fluids should be used for dissolving the substance for administration, shall be included in the particulars;

(b)the particulars specified in paragraph (2)(c) and (e) shall be so expressed as to relate to the substance in the liquid form in which it is to be administered; and

(c)an explanation shall accompany the warning set out in paragraph (2)(d) that the warning relates to the substance in the liquid form in which it is to be administered.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources